Ford’s October sales slide 10% amid supply chain issues

Ford’s October sales slide 10% amid supply chain issues


Ford F-150 pickup trucks at a dealership in Colma, California, on Friday, July 22, 2022.

David Paul Morris | Bloomberg | Getty Images

DETROIT – Ford Motor’s U.S. sales last month declined by 10% as the automaker battled through supply chain issues that delayed shipments to dealers.

The Detroit automaker on Wednesday reported sales of 158,327 new vehicles in October, which was off from nearly 176,000 units sold during the same month a year earlier. It was the second-straight month of year-over-year declines after two months of double-digit increases over subdued sales constrained by semiconductor shortages.

Ford’s October sales were far lower than the overall industry. Edmunds reports overall auto sales increased 9.1% compared with a year earlier to nearly 1.2 million vehicles sold.

Ford has experienced unique supply chain issues lately, including sourcing of its blue oval badges for highly profitable pickup trucks and SUVs. The automaker had roughly 40,000 vehicles awaiting parts to end the third quarter. It said last week it expects to complete and ship those vehicles to dealers by the end of the year.

Andrew Frick, Ford vice president of sales, distribution & trucks, said the automaker “continues to see strong demand for its vehicles” amid rising interest rates, record inflation and recessionary fears.

Ford said orders for 2023 model-year vehicles totaled 255,000. Roughly half of those were retail sales from previously placed orders, according to the company.

Sales of Ford’s profitable F-Series pickups were off by 17.4% last month from October 2021, contributing to a roughly 13% year-to-date decline heading into the last two months of the year. The company sold 11,196 models of its all-electric F-150 Lightning pickup through October, including 2,436 vehicles last month.

Ford’s 2022 all-electric vehicle sales totaled roughly 47,500 units through October, accounting for about 3% of the automaker’s sales. A majority of those sales were Mustang Mach-E crossovers, which have increased 44% compared with last year to more than 31,000 units.

Year-to-date sales of all of Ford’s vehicles, including its luxury Lincoln brand, totaled 1.54 million units through October, a 2.2% decrease from a year ago.

Ford is among a handful of automakers to report new monthly vehicle sales. Others — such as General Motors and Stellantis, formerly Fiat Chrysler — report sales only quarterly.

Ford’s October sales come a week after the company recorded a net loss of $827 million during the third quarter, weighed down by supply chain problems and costs related to disbanding its autonomous vehicle unit Argo AI.

The carmaker last week updated its guidance to forecast full-year adjusted earnings before interest and taxes of about $11.5 billion – the lowest end of its previously forecast earnings. It raised its full-year adjusted free cash flow forecast, however, to between $9.5 billion and $10 billion – up from $5.5 billion to $6.5 billion – on strength in the company’s automotive operations.



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More